CoChat

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Background Several clinical trials have reported inconsistent findings for the effect of fibrates on cardiovascular risk. We undertook a systematic review and meta-analysis to investigate the effects of fibrates on major clinical outcomes. Methods We systematically searched Medline, Embase, and the Cochrane Library for trials published between 1950 and March, 2010. We included prospective randomised controlled trials assessing the effects of fibrates on cardiovascular outcomes compared with placebo. Summary estimates of relative risk (RR) reductions were calculated with a random effects model. Outcomes analysed were major cardiovascular events, coronary events, stroke, heart failure, coronary revascularisation, all-cause mortality, cardiovascular death, non-vascular death, sudden death, new onset albuminuria, and drug-related adverse events. Findings We identified 18 trials providing data for 45 058 participants, including 2870 major cardiovascular events, 4552 coronary events, and 3880 deaths. Fibrate therapy produced a 10% RR reduction (95% CI 0-18) for major cardiovascular events (p=0.048) and a 13% RR reduction (7-19) for coronary events (p Interpretation Fibrates can reduce the risk of major cardiovascular events predominantly by prevention of coronary events, and might have a role in individuals at high risk of cardiovascular events and in those with combined dyslipidaemia. Funding National Health and Medical Research Council of Australia.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)60656-3

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

12 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 51 references

Research works printed but not linked: 1

  1. Drury, 2008, Reduced renal function (eGFR) and albuminuria in type 2 diabetes independently predict cardiovascular (CVD) events and mortality even in a low risk cohort: the FIELD Study, Circulation, 118, S1088

Cited by

See all 927

Metadata

Authors
Jun, M., Foote, C., Lv, J., Neal, B., Patel, A., Nicholls, S. J., Grobbee, D. E., Cass, A., Chalmers, J., & Perkovic, V.
Affiliations
  • The University of Sydney (AU)
  • Cleveland Clinic (US)
  • University Medical Center Utrecht (NL)
Venue
The Lancet
Publisher
Elsevier BV
Published
2010-05
Volume
375
Issue
9729
Pages
1875-1884
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2096210401
Cited by
927
References
49
Citations by year
2026: 17 · 2025: 29 · 2024: 37 · 2023: 52 · 2022: 54 · 2021: 57 · 2020: 48 · 2019: 42 · 2018: 49 · 2017: 58 · 2016: 66 · 2015: 66 · 2014: 79 · 2013: 77 · 2012: 83
FWCI
13.71
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders
Servier
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
fibrates, cardiovascular risk reduction, major cardiovascular events, coronary events, stroke, all-cause mortality, cardiovascular mortality, sudden death, albuminuria, drug-related adverse events, serum creatinine, hypertriglyceridemia, lipid-lowering therapy, statins, triglycerides, HDL cholesterol, LDL cholesterol, triglyceride-rich lipoproteins, coronary revascularization
MeSH terms
Hypolipidemic Agents, Cardiovascular Diseases, Clofibric Acid, Humans, Randomized Controlled Trials as Topic, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(10)60656-3
The paper
Jun, M., Foote, C., Lv, J., Neal, B., Patel, A., Nicholls, S. J., Grobbee, D. E., Cass, A., Chalmers, J., & Perkovic, V. (2010). Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. The Lancet. https://doi.org/10.1016/s0140-6736(10)60656-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.